NL7808319A - 2-pyridyl- en 2-pyrimidylderivaten. - Google Patents

2-pyridyl- en 2-pyrimidylderivaten.

Info

Publication number
NL7808319A
NL7808319A NL787808319A NL7808319A NL7808319A NL 7808319 A NL7808319 A NL 7808319A NL 787808319 A NL787808319 A NL 787808319A NL 7808319 A NL7808319 A NL 7808319A NL 7808319 A NL7808319 A NL 7808319A
Authority
NL
Netherlands
Prior art keywords
pyridyl
pyrimidyl derivatives
pyrimidyl
derivatives
Prior art date
Application number
NL787808319A
Other languages
English (en)
Original Assignee
Boehringer Sohn Ingelheim
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Sohn Ingelheim filed Critical Boehringer Sohn Ingelheim
Publication of NL7808319A publication Critical patent/NL7808319A/nl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79Acids; Esters
    • C07D213/80Acids; Esters in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Medicinal Preparation (AREA)
NL787808319A 1977-08-10 1978-08-09 2-pyridyl- en 2-pyrimidylderivaten. NL7808319A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19772735919 DE2735919A1 (de) 1977-08-10 1977-08-10 Neue 2-pyridyl- und 2-pyrimidylaminobenzoesaeuren

Publications (1)

Publication Number Publication Date
NL7808319A true NL7808319A (nl) 1979-02-13

Family

ID=6016013

Family Applications (1)

Application Number Title Priority Date Filing Date
NL787808319A NL7808319A (nl) 1977-08-10 1978-08-09 2-pyridyl- en 2-pyrimidylderivaten.

Country Status (32)

Country Link
US (1) US4241068A (nl)
JP (1) JPS5430177A (nl)
AT (1) AT370415B (nl)
AU (1) AU520240B2 (nl)
BE (1) BE869640A (nl)
BG (1) BG30472A1 (nl)
CA (1) CA1111037A (nl)
CH (1) CH649289A5 (nl)
CS (1) CS202506B2 (nl)
DD (1) DD140351A5 (nl)
DE (1) DE2735919A1 (nl)
DK (1) DK148019C (nl)
ES (5) ES472143A1 (nl)
FI (1) FI71555C (nl)
FR (1) FR2400017A1 (nl)
GB (1) GB2002764B (nl)
GR (1) GR65024B (nl)
HU (1) HU179933B (nl)
IE (1) IE47228B1 (nl)
IT (1) IT1107960B (nl)
LU (1) LU80094A1 (nl)
MX (1) MX5672E (nl)
NL (1) NL7808319A (nl)
NO (1) NO152605C (nl)
NZ (1) NZ188101A (nl)
PH (1) PH19117A (nl)
PL (2) PL115778B1 (nl)
PT (1) PT68407A (nl)
SE (1) SE444170B (nl)
SU (2) SU735168A3 (nl)
YU (1) YU40832B (nl)
ZA (1) ZA784501B (nl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3100516A1 (de) * 1981-01-10 1982-08-12 C.H. Boehringer Sohn, 6507 Ingelheim Pyridylaminobenzoesaeuren, ihre herstellung und verwendung
FR2533567A1 (fr) * 1982-09-23 1984-03-30 Ki I Farmakologii 2-(orthocarboxyphenylamino)-6h-pyrimido (2,1-b)-quinazolone-6 et ses derives, leur procede de preparation et leur application therapeutique
US4610991A (en) * 1983-04-18 1986-09-09 Sterling Drug Inc. Antihypertensive pyridylaminobenzamide compounds
JPS60100559A (ja) * 1983-11-05 1985-06-04 Morishita Seiyaku Kk 2−アニリノ−1,6−ジヒドロ−6−オキソ−5−ピリミジンカルボン酸誘導体,その製法及び該化合物を含有する抗アレルギ−剤
US4584379A (en) * 1985-01-22 1986-04-22 Merrell Dow Pharmaceuticals Inc. Isoquinoline thromboxane synthetase inhibitors
ATE68789T1 (de) * 1985-10-16 1991-11-15 Merck Frosst Canada Inc 2-substituierte chinoline.
GB9615950D0 (en) * 1996-07-30 1996-09-11 Univ Warwick Variable reluctance machines
US6022884A (en) 1997-11-07 2000-02-08 Amgen Inc. Substituted pyridine compounds and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1064259A (en) * 1963-12-19 1967-04-05 Union Pharma Scient Appl New derivatives of 2-anilino-nicotinic acid and process for their preparation
GB1162287A (en) * 1967-11-07 1969-08-20 Union Pharma Scient Appl New Salts of 2-Anilino-Nicotinic Acids
GB1264798A (nl) * 1968-07-10 1972-02-23
ES416847A1 (es) * 1973-07-12 1976-03-01 Hermes Sa Lab Procedimiento para la obtencion de derivados del acido ni- cotinico.

Also Published As

Publication number Publication date
YU40832B (en) 1986-06-30
FI782039A (fi) 1979-02-11
FR2400017A1 (fr) 1979-03-09
ZA784501B (en) 1980-04-30
HU179933B (en) 1983-01-28
ES480623A1 (es) 1980-01-01
NO152605C (no) 1985-10-23
LU80094A1 (de) 1979-09-07
NZ188101A (en) 1981-01-23
BE869640A (fr) 1979-02-09
DD140351A5 (de) 1980-02-27
CS202506B2 (en) 1981-01-30
GB2002764A (en) 1979-02-28
YU191678A (en) 1983-01-21
IE781618L (en) 1979-02-10
NO782707L (no) 1979-02-13
DE2735919C2 (nl) 1988-10-27
FI71555B (fi) 1986-10-10
AU3877278A (en) 1980-02-14
MX5672E (es) 1983-12-08
IE47228B1 (en) 1984-01-25
JPS6231704B2 (nl) 1987-07-09
DK148019B (da) 1985-02-04
DK351978A (da) 1979-02-11
ATA549278A (de) 1982-08-15
AU520240B2 (en) 1982-01-21
AT370415B (de) 1983-03-25
PL115889B1 (en) 1981-05-30
PL115778B1 (en) 1981-04-30
PT68407A (de) 1978-09-01
CA1111037A (en) 1981-10-20
CH649289A5 (de) 1985-05-15
BG30472A1 (en) 1981-06-15
US4241068A (en) 1980-12-23
DK148019C (da) 1985-07-01
NO152605B (no) 1985-07-15
ES475456A1 (es) 1979-05-01
FR2400017B1 (nl) 1983-03-11
ES472143A1 (es) 1979-03-16
GR65024B (en) 1980-06-16
SE7808530L (sv) 1979-02-11
SU735168A3 (ru) 1980-05-15
IT7850642A0 (it) 1978-08-08
JPS5430177A (en) 1979-03-06
GB2002764B (en) 1982-08-04
PL208942A1 (nl) 1979-12-03
SE444170B (sv) 1986-03-24
IT1107960B (it) 1985-12-02
SU886743A3 (ru) 1981-11-30
FI71555C (fi) 1987-01-19
ES475457A1 (es) 1979-11-16
DE2735919A1 (de) 1979-02-22
ES480622A1 (es) 1980-01-01
PH19117A (en) 1986-01-06

Similar Documents

Publication Publication Date Title
NL7803432A (nl) Aceetamidederivaten.
NO784329L (no) Stilbenderivater.
NL7802170A (nl) Sierraad.
NL7803036A (nl) 4-(5-fluormethyl-2-pyridyloxy)fenoxyalkaan- carbonzuren en derivaten daarvan.
NL7806245A (nl) Carbostyrilderivaten.
NL7805253A (nl) N- alkylpiperidinederivaten.
NL7807702A (nl) Interferometrische versterker.
NO783642L (no) Imidazolidenderivater.
NL7803296A (nl) Cyclohexaandionderivaten.
NL7802671A (nl) Cefemderivaten en hun bereiding.
NL7800262A (nl) Oxazolinoazetidine derivaten.
NL7808743A (nl) Versterker.
BE871702A (fr) Isochromanes, isothiochromanes, 2-benzoxepines et 2-benzothiepines
SE7804778L (sv) Triazinderivat
NL7801772A (nl) Fotocel.
NL7801708A (nl) 1-oxadethiacepham-derivaten.
IT7820800A0 (it) Derivati di immidazolo.
NL7808011A (nl) Norbornaan- en norborneen-derivaten.
NL7808319A (nl) 2-pyridyl- en 2-pyrimidylderivaten.
NL7801289A (nl) Oxadiazolopyrimidinederivaten.
NL7811070A (nl) 2-imino-imidazolidinederivaten.
NL7808036A (nl) Nitrosoureum derivaten.
NL7704087A (nl) Basisch gesubstitueerde xanthinederivaten.
NL7803725A (nl) 4-alkylthio-2-trifluormethylalkaansulfonaniliden en derivaten daarvan.
NL7801927A (nl) Gesubstitueerde pyrrolochinoxalinonen en pyrrolobenzodiazepinonen.

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed